Electrostimulation PROTOCOL Incontinence

Sponsor
Hospital Universitário Professor Edgard Santos (Other)
Overall Status
Completed
CT.gov ID
NCT03682926
Collaborator
(none)
20
2
14

Study Details

Study Description

Brief Summary

To verify the effect of an adapted electrostimulation (EE) protocol for stress and mixed urinary incontinence (SUI / M) and its impact on quality of life (QoL)

Condition or Disease Intervention/Treatment Phase
  • Other: Electro-stimulation
N/A

Detailed Description

Controlled and randomized clinical trial performed at the Physiotherapy Outpatient Clinic at the Magalhães Neto Pavilion of ComHUPES / UFBA. Women aged between 30 and 65 years and diagnosis of SUI / IUM. The patients were allocated to two groups (GA) submitted to selective electrostimulation for tonic fiber, phasic fibers IIa / IIb and different times of electrical stimulation; (GB) used 50hz for all fibers by 20mm, both answered the questionnaire King's Health Questionnaire (KHQ).

Study Design

Study Type:
Interventional
Actual Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
EFFECT OF A PROTOCOL Electrostimulation for Urinary Incontinence and Its Influence on WOMEN 'S QUALITY OF LIFE
Study Start Date :
Oct 1, 2014
Actual Primary Completion Date :
Nov 1, 2014
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: electrostimulation individualized

Selective electrostimulation for tonic fiber, phasic fiber FIa and FIIb and different stimulus times. Muscle fibers (Tonic) with a frequency of 20Hz, pulse width (t) of 700μs to 1ms, time of rise and fall of the wave of 1.0 seconds, duration of contraction and repetition was based on the perineal evaluation But the resting time was twice as long as sustained. For the IIa (phasic) fibers the frequency was 50 Hz with a pulse width of 400μs to 500μs, for 3 seconds of sustentation and 6 seconds of relaxation, time of rise of 0,5 seconds and 0,5 seconds of descent. E for type IIb (phasic) fibers, 80 Hz frequency, pulse width 250μs to 400μs, 1 second contraction for 3 seconds rest and 0.2 seconds rise and fall time.

Other: Electro-stimulation
Intracavitary electrostimulation with Quark medical vaginal electrode for perineal muscle strengthening protocol.
Other Names:
  • electro physical therapy
  • dualpex 961 quark
  • Active Comparator: electrostimulation with fixed protocol

    Intervention -Electro-stimulate all fibers with a single electrical parameter. Pulse width 700μs, rise and fall time of 2 seconds each, sustain time of 4 seconds and rest 8 seconds for 20 minutes, the intensity will be modulated, as in the previous group by patient tolerance in milliamperes.

    Other: Electro-stimulation
    Intracavitary electrostimulation with Quark medical vaginal electrode for perineal muscle strengthening protocol.
    Other Names:
  • electro physical therapy
  • dualpex 961 quark
  • Outcome Measures

    Primary Outcome Measures

    1. contractile function of the perineal musculature [3 months]

      Perineal muscle function evaluated subjectively by vaginal touch using the PERFECT system to measure strength (graded from 0 to 5), strength (holding capacity of contraction recorded in seconds) and number of contractions of tonic and phasic fibers (ability to repeat muscle contractions perineal). Objectively, the vaginal cones were used to determine which load the patient was able to support (kit with 5 cones with weights ranging from 20 to 70g)

    Secondary Outcome Measures

    1. King's Health Questionnaire [3 months]

      It allows qualitative evaluation of the impact of urinary incontinence on the quality of life of women, it is responsible for 20 questions, divided into 8 domains, in addition to these domains, there are two other independent scales: the first evaluates the severity of UI (severity measures) and the second, the presence and intensity of urinary symptoms through the scale of urinary symptoms (VAS) where there is a graduation from 0 to 10, where the higher the score, the higher the severity

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    30 Years to 65 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • women between the ages of 30 and 65

    • With diagnosis of stress urinary incontinence and / or mixed

    • Perineal muscle weakness

    • Accepted to sign the TCLE

    Exclusion Criteria:
    • Women with neurological changes

    • Pregnant women

    • IUD use

    • Pacemaker

    • Genitourinary tract infection

    • Cancer

    • Refuse to sign the TCLE

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Hospital Universitário Professor Edgard Santos

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    ROSANA CRISTINA PEREIRA DE ANDRADE, Dra, Hospital Universitário Professor Edgard Santos
    ClinicalTrials.gov Identifier:
    NCT03682926
    Other Study ID Numbers:
    • ROAND2015
    First Posted:
    Sep 25, 2018
    Last Update Posted:
    Oct 3, 2018
    Last Verified:
    Oct 1, 2018
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 3, 2018